Merck to Announce Multiple Scientific Efforts to Combat COVID-19
Dateline City:
KENILWORTH, N.J.
KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, will today announce three significant scientific initiatives to combat COVID-19: two agreements to develop potential vaccines against SARS-CoV-2, and a research collaboration to advance the development of a novel antiviral candidate. Today’s announcements are:
Language:
English
Contact:
Media Contacts:
Patrick Ryan
+1 (201) 452-2409
Imraan Munshi
+1 (267) 884-1358
Investor Contacts:
Peter Dannenbaum
+1 (908) 740-1037
Michael DeCarbo
+1 (908) 740-1807
Ticker Slug:
Ticker:
MRK
Exchange:
NYSE
@Merck
Read Original Article: Merck to Announce Multiple Scientific Efforts to Combat COVID-19 »